EnEnduvo Enterprise Licenses, Maintenance and Support Renewal
Closed Solicitation Posted
- Solicitation number
- NOI-NIAID-25-2247891
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 513210 Software Publishers
- Place of performance
- Rockville, Maryland 20852, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, intends to negotiate a sole source procurement for an annual renewal of Enduvo Enterprise Edition PRIVATE Creator Software License. The procurement will support the NIAID Biovisualization Laboratory's virtual and augmented reality (VR/AR) capabilities for research and educational training purposes. The software is critical to the laboratory's operations, having been in use for over four years and serving as the backbone for existing and planned projects. Capability statements from potential alternative sources are due by 11:00 AM EST on December 12, 2024, and must be submitted through the NIAID electronic Simplified Acquisition Submission System (eSASS). The statutory authority for this sole source requirement is 41 U.S.C. 1901(a)(1), which allows for procurement from only one responsible source that can satisfy agency requirements.
The solicitation does not include any specific set-aside designations and is classified under NAICS category 513210 for Software Publishers. The contract is specifically with Enduvo Inc., located in Peoria, Illinois, for their proprietary software platform. The renewal period covers January 1, 2025 to December 31, 2025, and includes Enterprise Edition License Maintenance, Standard Support 8x5, and NIH-Specific PUBLIC Domain Creator License(s). The place of performance is located in Rockville, MD, where the BioViz Lab currently hosts four high-end workstations with advanced computational and graphics processing hardware. The software licenses will support the lab's dedicated facility for providing NIAID staff with advanced visualization experiences, with Enduvo holding exclusive ownership of all software components.
Notice text
This is a Notice of Intent, NOT a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Enduvo Inc., 2601 W. Lake Avenue, Suite A6-110, Peoria, Illinois 61615, to procure an annual renewal of Enduvo Enterprise Edition PRIVATE Creator Software License, proprietary in nature, to the support of the established the NIAID Biovisualization Laboratory.
The NIAID, Bioinformatics and Computational Biosciences Branch is seeking to purchase an annual renewal of the Enduvo software platform, which is used in creating virtual and augmented reality (VR/AR) for training research and educational preparation in the NIAID Biovisualization Laboratory. This is a program aimed toward developing a dedicated facility to provide NIAID staff with various options for advanced visualization experiences. Currently located at 5601 Fishers Lane, the BioViz Lab hosts four workstations, each with high-end computational and graphics processing hardware to support the most advanced requirements of VR and AR devices and applications. This software has been in use for more than 4 plus year, and is the backbone of existing and planned projects. Therefore, this requirement is to continue access to our existing software and concurrent licenses. Enduvo software and all of its component parts are the exclusive property of Enduvo. The licenses are proprietary software which can only be obtained from the manufacturer.
Specifications:
Enduvo Enterprise Edition PRIVATE Creator License includes Enduvo Enterprise Edition License Maintenance, Enduvo Enterprise Edition Standard Support 8x5, NIH-Specific PUBLIC Domain Creator License(s) Platform
Software Renewal Period: 1/1/2025 – 12/31/2025
The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply or service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability by 11:00am - EST, Thursday, December 12, 2024. All capability statements must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov. All vendors must
register in the eSASS system to submit a quotation. Instructions on how to register / submit
capability statements are included on the website. Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f). All responsible sources may submit an offer that will be considered by this Agency.
Files
| File | Type | Posted |
|---|---|---|
| 2_NOI-NIAID-25-2247891 FBO.doc | DOC document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity